• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症及其围手术期管理的最新进展

An Update on Systemic Sclerosis and its Perioperative Management.

作者信息

Carr Zyad J, Klick John, McDowell Brittany J, Charchaflieh Jean G, Karamchandani Kunal

机构信息

Department of Anesthesiology, Yale New Haven Hospital, New Haven, CT 06510 USA.

Yale University School of Medicine, New Haven, CT 06510 USA.

出版信息

Curr Anesthesiol Rep. 2020;10(4):512-521. doi: 10.1007/s40140-020-00411-8. Epub 2020 Aug 29.

DOI:10.1007/s40140-020-00411-8
PMID:32904358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7455511/
Abstract

PURPOSE OF REVIEW

Systemic sclerosis or scleroderma (SSc) is a systemic, immune-mediated disease characterized by abnormal cutaneous and organ-based fibrosis that results in progressive end-organ dysfunction and decreased survival. SSc results in significant challenges for the practicing anesthesiologist due to its rarity, multi-system involvement, and limited evidence-based guidance for optimal perioperative care. In this update, we briefly discuss the recent evidence on the pathophysiology and current management of SSc, review the anesthesia-related literature, and extrapolate these observations into an optimal perioperative strategy for the care of SSc patients.

RECENT FINDINGS

Evidence shows that patients with SSc demonstrate an increased risk for perioperative myocardial infarction, high rates of interstitial lung disease, pulmonary arterial hypertension, neurological disease, gastric dysmotility disorders, and challenging airway management, all findings that may result in suboptimal perioperative outcomes.

SUMMARY

Advances in SSc medical management have resulted in improved survival, likely increasing the number of patients who will be exposed to perioperative care. Optimal perioperative management and risk stratification should expand beyond the well-described airway challenges and consider numerous systemic manifestations of systemic sclerosis such as pulmonary arterial hypertension, interstitial lung disease, and cardiac sequelae.

摘要

综述目的

系统性硬化症(SSc),又称硬皮病,是一种系统性、免疫介导的疾病,其特征为皮肤和器官出现异常纤维化,导致进行性终末器官功能障碍和生存率降低。由于SSc较为罕见、累及多系统且缺乏关于最佳围手术期护理的循证指南,给执业麻醉医师带来了重大挑战。在本次更新中,我们简要讨论了关于SSc病理生理学和当前治疗的最新证据,回顾了与麻醉相关的文献,并将这些观察结果推断为针对SSc患者护理的最佳围手术期策略。

最新发现

证据表明,SSc患者围手术期心肌梗死风险增加,间质性肺疾病、肺动脉高压、神经疾病、胃动力障碍发生率高,气道管理具有挑战性,所有这些发现都可能导致围手术期结果不理想。

总结

SSc医疗管理的进展提高了生存率,可能会增加接受围手术期护理的患者数量。最佳围手术期管理和风险分层应超越已充分描述的气道挑战,考虑系统性硬化症的多种全身表现,如肺动脉高压、间质性肺疾病和心脏后遗症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/7455511/2943bcafed7c/40140_2020_411_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/7455511/2943bcafed7c/40140_2020_411_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/7455511/2943bcafed7c/40140_2020_411_Fig1_HTML.jpg

相似文献

1
An Update on Systemic Sclerosis and its Perioperative Management.系统性硬化症及其围手术期管理的最新进展
Curr Anesthesiol Rep. 2020;10(4):512-521. doi: 10.1007/s40140-020-00411-8. Epub 2020 Aug 29.
2
Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH).系统性硬化症相关肺动脉高压(SSc-PAH)治疗面临的挑战与进展
Ther Clin Risk Manag. 2019 Dec 13;15:1427-1442. doi: 10.2147/TCRM.S219024. eCollection 2019.
3
Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.系统性硬化症患者肺动脉高压的管理
Integr Blood Press Control. 2020 Mar 23;13:15-29. doi: 10.2147/IBPC.S232038. eCollection 2020.
4
Determinants of morbidity and mortality of systemic sclerosis in Canada.加拿大系统性硬化症发病率和死亡率的决定因素。
Semin Arthritis Rheum. 2010 Feb;39(4):269-77. doi: 10.1016/j.semarthrit.2008.06.002. Epub 2008 Aug 15.
5
Lung transplantation in patients with scleroderma.硬皮病患者的肺移植。
Curr Opin Rheumatol. 2013 Nov;25(6):714-8. doi: 10.1097/01.bor.0000434670.39773.a8.
6
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).系统性硬化症患者的间质性肺病:基于个体化医学的系统性硬化症相关间质性肺病(SSc-ILD)预测和药物筛选模型。
Front Immunol. 2020 Sep 4;11:1990. doi: 10.3389/fimmu.2020.01990. eCollection 2020.
7
Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.系统性硬化症的指端溃疡和皮肤亚组:西班牙RESCLE注册研究中的临床、免疫学、甲襞毛细血管镜检查及生存差异
Semin Arthritis Rheum. 2016 Oct;46(2):200-208. doi: 10.1016/j.semarthrit.2016.04.007. Epub 2016 May 18.
8
Systemic sclerosis. A clinical overview.系统性硬化症。临床概述。
Adv Exp Med Biol. 1999;455:73-83.
9
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.利妥昔单抗治疗系统性硬化症。我们的经验和文献复习。
Autoimmun Rev. 2015 Nov;14(11):1072-8. doi: 10.1016/j.autrev.2015.07.008. Epub 2015 Jul 22.
10
Systemic Sclerosis: Current State and Survival After Lung Transplantation.系统性硬化症:肺移植后的现状与生存率
Cureus. 2021 Jan 20;13(1):e12797. doi: 10.7759/cureus.12797.

引用本文的文献

1
Multimodal Regional Anesthesia Combining Spinal and Erector Spinae Plane Block for Spine Surgery in a High-Risk Patient with Systemic Sclerosis: A Case Report.多模式区域麻醉联合脊髓麻醉和竖脊肌平面阻滞用于系统性硬化症高危患者的脊柱手术:一例报告
Anesth Pain Med. 2025 Mar 29;15(2):e160051. doi: 10.5812/aapm-160051. eCollection 2025 Apr 30.
2
Systemic sclerosis and acute heart failure in prosthetic heart valve patients: A retrospective analysis.人工心脏瓣膜患者的系统性硬化症与急性心力衰竭:一项回顾性分析。
J Scleroderma Relat Disord. 2024 Sep 27:23971983241278853. doi: 10.1177/23971983241278853.
3
Perioperative Complications in Patients with Systemic Sclerosis: A Comparative Cohort Analysis.

本文引用的文献

1
Anesthetic Management of a Patient With Systemic Sclerosis and Microstomia.一名系统性硬化症合并小口畸形患者的麻醉管理
Anesth Prog. 2020 Spring;67(1):28-34. doi: 10.2344/anpr-66-03-07.
2
Colonic Manifestations and Complications Are Relatively Under-Reported in Systemic Sclerosis: A Systematic Review.系统性硬化症中结直肠表现和并发症的报道相对较少:系统评价。
Am J Gastroenterol. 2019 Dec;114(12):1847-1856. doi: 10.14309/ajg.0000000000000397.
3
Individuals With Scleroderma May Have Increased Risk of Sleep-Disordered Breathing.硬皮病患者可能存在睡眠呼吸障碍风险增加的情况。
系统性硬化症患者的围手术期并发症:一项比较队列分析。
Med Res Arch. 2023 Oct;11(10). doi: 10.18103/mra.v11i10.4606. Epub 2023 Oct 25.
4
Increased rate of complications following total knee arthroplasty in patients with systemic sclerosis.系统性硬化症患者全膝关节置换术后并发症发生率增加。
Int Orthop. 2023 Oct;47(10):2563-2569. doi: 10.1007/s00264-023-05873-z. Epub 2023 Jun 24.
5
Systemic sclerosis. Part II: perioperative considerations.系统性硬化症。第二部分:围手术期注意事项。
BJA Educ. 2023 Mar;23(3):101-109. doi: 10.1016/j.bjae.2022.10.003. Epub 2023 Jan 4.
6
Cricothyrotomy for an Unexpected Cannot Intubate, Cannot Ventilate Situation for a Patient with Chronic Graft-Versus-Host Disease After Induction of General Anesthesia: A Case Report.全麻诱导后慢性移植物抗宿主病患者出现无法插管、无法通气时行环甲膜切开术:1 例报告。
Am J Case Rep. 2023 Feb 20;24:e938992. doi: 10.12659/AJCR.938992.
7
Systemic sclerosis. Part I: epidemiology, diagnosis and therapy.系统性硬化症。第一部分:流行病学、诊断与治疗。
BJA Educ. 2023 Feb;23(2):66-75. doi: 10.1016/j.bjae.2022.10.004. Epub 2023 Jan 10.
8
Systemic sclerosis cutaneous expression: Management of skin fibrosis and digital ulcers.系统性硬化症的皮肤表现:皮肤纤维化和指端溃疡的管理
Ann Med Surg (Lond). 2021 Nov 2;71:102984. doi: 10.1016/j.amsu.2021.102984. eCollection 2021 Nov.
9
Endothelial-to-mesenchymal transition in systemic sclerosis.系统性硬皮病中的内皮细胞向间充质细胞转化。
Clin Exp Immunol. 2021 Jul;205(1):12-27. doi: 10.1111/cei.13599. Epub 2021 Apr 18.
J Clin Sleep Med. 2019 Nov 15;15(11):1665-1669. doi: 10.5664/jcsm.8036.
4
Lung-protective ventilation for the surgical patient: international expert panel-based consensus recommendations.肺保护性通气策略用于外科患者:基于国际专家小组的共识推荐。
Br J Anaesth. 2019 Dec;123(6):898-913. doi: 10.1016/j.bja.2019.08.017. Epub 2019 Oct 3.
5
Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry.脉冲震荡法测定系统性硬化症患者小气道功能障碍的患病率增加。
Rheumatology (Oxford). 2020 Mar 1;59(3):641-649. doi: 10.1093/rheumatology/kez340.
6
Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.结缔组织病相关间质性肺疾病急性加重的临床特征和结局:来自印度的单中心研究。
Int J Rheum Dis. 2019 Sep;22(9):1741-1745. doi: 10.1111/1756-185X.13666. Epub 2019 Jul 22.
7
Systemic sclerosis and the risk of perioperative major adverse cardiovascular events for inpatient non-cardiac surgery.系统性硬化症与住院非心脏手术围手术期主要不良心血管事件的风险。
Int J Rheum Dis. 2019 Jun;22(6):1023-1028. doi: 10.1111/1756-185X.13537. Epub 2019 Mar 4.
8
Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases.甲氨蝶呤在免疫介导的炎症性疾病中的心血管效应。
Exp Ther Med. 2019 Feb;17(2):1024-1029. doi: 10.3892/etm.2018.6992. Epub 2018 Nov 19.
9
Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality.早期全身性硬皮病中严重的胃肠道疾病与早期死亡率相关。
Rheumatology (Oxford). 2019 Apr 1;58(4):636-644. doi: 10.1093/rheumatology/key350.
10
Risk factors for mortality and mortality rates in interstitial lung disease patients in the intensive care unit.重症监护病房间质性肺疾病患者的死亡风险因素和死亡率。
Eur Respir Rev. 2018 Nov 21;27(150). doi: 10.1183/16000617.0061-2018. Print 2018 Dec 31.